Literature DB >> 21145353

First clinical experiences about the neurotoxic envenomings inflicted by lowland populations of the Balkan adder, Vipera berus bosniensis.

Tamás Malina1, László Krecsák, Dušan Jelić, Tomislav Maretić, Tamás Tóth, Marijan Siško, Nenad Pandak.   

Abstract

The first overall clinical description of envenomings by the lowland populations of the Balkan adder (Vipera berus bosniensis) is provided by this study. Fifty-four incidents have been collected retrospectively from the south-western Hungarian and the northern Croatian distribution area of the taxon. There were five (9%) asymptomatic, 24 (44%) mild, 12 (22%) moderate, 12 (22%) severe, and one fatal (2%) case according to the Poisoning Severity Score. The single death is a 60-year-old Hungarian case that was caused by V.b. bosniensis. Average hospitalisation was 2.75 days. The most common systemic symptoms were gastrointestinal disorders, ECG changes, persisting hypotension and neurological disorders. The initial phase of neurotoxic manifestations was always expressed in cranial nerve disturbances: ptosis, external ophthalmoplegia, diplopia, reduced focusing capability and blurred vision. Neuromuscular paralysis progressed to dyspnoea and lower limb paralysis in the most severe cases. Unusual symptoms were fluctuating arterial hypertension, drowsiness, and hypokalaemia. Laboratory results reveal leucocytosis, while deviation in the other laboratory values is not common. Envenomings by V.b. bosniensis significantly differ from those by the European adder (Vipera berus berus) in lower manifestation rate of extensive oedema, anaemia, CNS depression, and haematuria but the development of neuromuscular paralysis is high (20%). Their bites rather resulted in mild and moderate local symptoms in envenomed patients than those inflicted by the nominate form. This study presents the evidence of the frequent neurotoxic manifestations in Balkan adder-bitten patients for the first time, which strongly suggests that the venom of the lowland populations of V.b. bosniensis has neurotoxic activity. Crown
Copyright © 2010. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21145353     DOI: 10.1016/j.neuro.2010.11.007

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  7 in total

1.  [Venomous snakes in Germany and Europe].

Authors:  A Montag
Journal:  Hautarzt       Date:  2018-08       Impact factor: 0.751

Review 2.  Biochemistry and toxicology of proteins and peptides purified from the venom of Vipera berus berus.

Authors:  Jüri Siigur; Ene Siigur
Journal:  Toxicon X       Date:  2022-06-12

Review 3.  Should We Be Using the Poisoning Severity Score?

Authors:  Evan S Schwarz; Kathryn T Kopec; Timothy J Wiegand; Paul M Wax; Jeffrey Brent
Journal:  J Med Toxicol       Date:  2017-03-10

Review 4.  Endocrine and Metabolic Manifestations of Snakebite Envenoming.

Authors:  Saptarshi Bhattacharya; Aishwarya Krishnamurthy; Maya Gopalakrishnan; Sanjay Kalra; Viny Kantroo; Sameer Aggarwal; Vineet Surana
Journal:  Am J Trop Med Hyg       Date:  2020-10       Impact factor: 3.707

Review 5.  Antivenom for Neuromuscular Paralysis Resulting From Snake Envenoming.

Authors:  Anjana Silva; Wayne C Hodgson; Geoffrey K Isbister
Journal:  Toxins (Basel)       Date:  2017-04-19       Impact factor: 4.546

Review 6.  Neurotoxicity in snakebite--the limits of our knowledge.

Authors:  Udaya K Ranawaka; David G Lalloo; H Janaka de Silva
Journal:  PLoS Negl Trop Dis       Date:  2013-10-10

7.  Varespladib (LY315920) Appears to Be a Potent, Broad-Spectrum, Inhibitor of Snake Venom Phospholipase A2 and a Possible Pre-Referral Treatment for Envenomation.

Authors:  Matthew Lewin; Stephen Samuel; Janie Merkel; Philip Bickler
Journal:  Toxins (Basel)       Date:  2016-08-25       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.